about
Determination of genetic predisposition to patent ductus arteriosus in preterm infantsQuality of EHR data extractions for studies of preterm birth in a tertiary care center: guidelines for obtaining reliable data.Oligonucleotide-based strategies to reduce gene expression.Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infantsPossible roles of bilirubin and breast milk in protection against retinopathy of prematurity.Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormoneHyperglycemia as a risk factor for the development of retinopathy of prematuritySequence variants in oxytocin pathway genes and preterm birth: a candidate gene association studyCytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit.Replication of genetic associations in the inflammation, complement, and coagulation pathways with intraventricular hemorrhage in LBW preterm neonates.Replication of a genome-wide association study of birth weight in preterm neonatesGenetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants.Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates.Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.Applying deep DNA sequencing to common, complex pediatric traits.Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns.Predicting gestational age using neonatal metabolic markers.Association of amino acids with common complications of prematurity.Individual and center-level factors affecting mortality among extremely low birth weight infants.Candidate gene linkage approach to identify DNA variants that predispose to preterm birth.Genetic contributions to the development of retinopathy of prematurityMaternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.Necrotizing Enterocolitis Is Not Associated With Sequence Variants in Antioxidant Response Genes in Premature InfantsGenetics of patent ductus arteriosus susceptibility and treatment.Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.Antisense inhibition of epidermal growth factor receptor decreases expression of human surfactant protein A.Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.A functional ATG16L1 (T300A) variant is associated with necrotizing enterocolitis in premature infants.Peritoneal dialysis in an extremely low-birth-weight infant with acute kidney injury.Genetic Modifiers of Patent Ductus Arteriosus in Term Infants.Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation.A Potential Role for the NOD1 Variant (rs6958571) in Gram-Positive Blood Stream Infection in ELBW Infants.Polymorphisms in NR5A2, gene encoding liver receptor homolog-1 are associated with preterm birth.Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn.Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus.Application of kinetic polymerase chain reaction and molecular beacon assays to pooled analyses and high-throughput genotyping for candidate genes.Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis.
P50
Q24645265-EDC4E187-4E7C-4ADF-90D3-8E52068FCA4CQ31088088-E96A69ED-2BDF-453C-8F20-3A6EA6599B46Q34110007-C926A8B4-7826-4CB5-8C4A-CF761A2E7949Q34134402-8BA2B757-BEC4-4BA9-906C-7EF78390E906Q34299394-0DC39AE6-500F-46F2-96DF-3690C279A9B6Q34551043-D192D843-F212-4B8B-8B8B-DB6A61B8FD00Q34660271-408504B7-1875-4D2B-8B4D-71E6872D34F1Q34725976-3EFE063F-13C3-435F-8345-F1B996CFF76BQ34868144-21190514-50E7-4EAE-AB2A-1A7CDE550FD0Q35046594-AD1B5FC5-0C48-4CC0-A820-00B1DD65B669Q35051464-872F550A-0AE1-44EB-9BB7-EEE22C244B57Q35613131-722D02B8-51F3-4089-BE69-D8009652D59AQ35899112-35E9B42E-817D-4ED3-BFD2-2C89B0921F22Q35910561-734547A5-9D39-4BB4-A77A-6196B95EDE25Q36017512-3D45C725-CA82-4046-9BCB-9298A0703400Q36322633-1B73519A-D84E-4DD6-B6F8-FE77F1CE5A6EQ36425779-2B45C46E-0EAF-466F-AD38-76E748A360E9Q36555392-5F8D4981-AFF9-40E7-BCA4-9931408E66A1Q36731296-E89B2EE7-CB1D-4D8A-9C08-877EE1DFF915Q36864043-D34E526F-BBF4-445C-BC68-8CF759E6E7D5Q36952241-9279F5F8-9E34-4EE0-AC33-352BAF657D83Q37088248-E9E68610-664F-42E3-9922-BEDF347018B2Q37164288-16DFADE3-8FFD-4A81-B654-0A2A9672E89AQ37252178-DC91401B-8220-4325-8469-C492AD393AADQ37322058-B8A147E6-6DE4-4AD9-A3DD-EBC3055D4A17Q37993349-C919BDD5-DD59-4B6B-B3AF-63D8224A99CFQ38297805-0E0D1B13-A77F-48D5-9564-33D2A6D1B0D0Q38311713-66201556-3048-496F-9928-A0756783761FQ38935495-5A5F6F64-7109-454B-A814-6D67E2A09F09Q39148501-51FA5099-8E1D-4523-8162-09801170DFC9Q39368496-19D3699F-0F2B-4965-A3C8-CD9026F077C8Q39655152-3482A589-D6A4-48A4-B1EC-F275E1DDB772Q39716474-81073246-A9EB-4584-B136-0AB3BAEC56AEQ40109767-0EE5B0EE-9D12-4FFA-8A74-361D5541C5CAQ40114006-9F484950-4DE6-4092-916F-C8E108304C46Q40127221-AEBEABCA-83E9-49FC-88EC-146245A70DCFQ40161847-000099A1-B73C-42DB-B8E4-4EAD5C40C610Q40161854-AACA59F3-8A87-49DA-94C5-EB2434D610ECQ42620988-2F67DC31-B771-45E0-B915-D2329C09AC22Q44231658-44AF742F-68D9-4154-B2C7-2461CC39E25A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John M Dagle
@ast
John M Dagle
@en
John M Dagle
@es
John M Dagle
@nl
type
label
John M Dagle
@ast
John M Dagle
@en
John M Dagle
@es
John M Dagle
@nl
prefLabel
John M Dagle
@ast
John M Dagle
@en
John M Dagle
@es
John M Dagle
@nl
P106
P1153
7003455690
P21
P31
P496
0000-0002-8238-6159